Fisher & Paykel Healthcare posts 15% rise in profit

Company News

by David Chau

Fisher & Paykel Healthcare (ASX:FPH) has reported that its full-year net profit (after tax) rose 15% to $NZ436 million last financial year.

The medical device manufacturer also says it earned a record operating revenue of $NZ815.5 (which is up 14%).

Fisher & Paykel has also increased its final dividend by 25%. It will pay 10 cents per share, plus 3.89 cents imputation credit for NZ residents. For non-residents, they will get a supplementary dividend of 1.76 cents per share.

As for outlook, the company will be launching a wide range of respiratory products in FY17 (with some used to treat sleep apnoea). The company also plans to spend NZ$200 million over the next 4-5 years and construct another building at its Auckland campus.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?